Display options
Cite
Jensen K, Thakur S, Patel A, et al. Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy. J Clin Med. 2020;9(8)doi: 10.3390/jcm9082481.
Jensen, K., Thakur, S., Patel, A., Mendonca-Torres, M. C., Costello, J., Gomes-Lima, C. J., Walter, M., Wartofsky, L., Burman, K. D., Bikas, A., Ylli, D., Vasko, V. V., & Klubo-Gwiezdzinska, J. (2020). Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy. Journal of clinical medicine, 9(8), . https://doi.org/10.3390/jcm9082481
Jensen, Kirk, et al. "Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy." Journal of clinical medicine vol. 9,8 (2020). doi: https://doi.org/10.3390/jcm9082481
Jensen K, Thakur S, Patel A, Mendonca-Torres MC, Costello J, Gomes-Lima CJ, Walter M, Wartofsky L, Burman KD, Bikas A, Ylli D, Vasko VV, Klubo-Gwiezdzinska J. Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy. J Clin Med. 2020 Aug 02;9(8). doi: 10.3390/jcm9082481. PMID: 32748840; PMCID: PMC7464493.
Copy Download .nbib Format: NLM
Share it on

J Clin Med. 2020 Aug 02;9(8). doi: 10.3390/jcm9082481.

Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy.

Journal of clinical medicine

Kirk Jensen, Shilpa Thakur, Aneeta Patel, Maria Cecilia Mendonca-Torres, John Costello, Cristiane Jeyce Gomes-Lima, Mary Walter, Leonard Wartofsky, Kenneth Dale Burman, Athanasios Bikas, Dorina Ylli, Vasyl V Vasko, Joanna Klubo-Gwiezdzinska

Affiliations

  1. Department of Pediatrics, Endocrine Division, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
  2. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20814, USA.
  3. MedStar Health Research Institute, MedStar Washington Hospital Center, Washington, DC 20010, USA.
  4. Endocrinology Division, University of Medicine, Tirana 1005, Albania.

PMID: 32748840 PMCID: PMC7464493 DOI: 10.3390/jcm9082481

Abstract

The detection of rare mutational targets in plasma (liquid biopsy) has emerged as a promising tool for the assessment of patients with cancer. We determined the presence of cell-free DNA containing the

Keywords: BRAFV600E; COLD-PCR; digital PCR; liquid biopsy; papillary thyroid cancer

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. Clin Chem. 2018 Dec;64(12):1762-1771 - PubMed
  2. Thyroid. 2016 Nov;26(11):1588-1597 - PubMed
  3. Clin Chim Acta. 2017 Aug;471:177-184 - PubMed
  4. Cancers (Basel). 2019 Dec 02;11(12): - PubMed
  5. Expert Rev Mol Diagn. 2016;16(3):265-8 - PubMed
  6. Exp Mol Pathol. 2018 Aug;105(1):153-159 - PubMed
  7. JAMA. 2013 Aug 7;310(5):535 - PubMed
  8. J Clin Endocrinol Metab. 2011 Nov;96(11):3390-7 - PubMed
  9. Oncotarget. 2017 Sep 21;8(50):87980-87996 - PubMed
  10. World J Surg Oncol. 2016 Sep 06;14(1):241 - PubMed
  11. NPJ Precis Oncol. 2017 Oct 17;1(1):36 - PubMed
  12. Cell. 2014 Oct 23;159(3):676-90 - PubMed
  13. J Clin Endocrinol Metab. 2009 Dec;94(12):5001-9 - PubMed
  14. BMC Med. 2017 Apr 6;15(1):75 - PubMed
  15. Exp Ther Med. 2019 Nov;18(5):3389-3396 - PubMed
  16. J Clin Invest. 2016 Mar 1;126(3):1052-66 - PubMed
  17. Clin Chim Acta. 2017 Feb;465:1-4 - PubMed
  18. Int J Clin Oncol. 2016 Oct;21(5):981-988 - PubMed
  19. Biochem Soc Trans. 2009 Apr;37(Pt 2):427-32 - PubMed
  20. J Cancer. 2020 Jan 1;11(4):932-939 - PubMed
  21. Front Oncol. 2020 Jan 10;9:1510 - PubMed
  22. J Clin Endocrinol Metab. 2019 May 1;104(5):1417-1428 - PubMed
  23. J Clin Oncol. 2018 Sep 20;36(27):2787-2795 - PubMed
  24. Lancet Oncol. 2016 Sep;17(9):1272-82 - PubMed
  25. Head Neck. 2013 Nov;35(11):1630-3 - PubMed
  26. BMC Res Notes. 2017 Oct 30;10(1):532 - PubMed
  27. J Mol Diagn. 2015 Jul;17(4):366-73 - PubMed
  28. N Engl J Med. 2016 Dec 8;375(23):2307 - PubMed
  29. Clin Chem. 2012 Mar;58(3):580-9 - PubMed
  30. Mol Diagn Ther. 2017 Jun;21(3):269-283 - PubMed
  31. J Clin Endocrinol Metab. 2005 Dec;90(12):6373-9 - PubMed
  32. Int J Surg. 2017 May;41 Suppl 1:S55-S59 - PubMed
  33. Sci Rep. 2018 Nov 30;8(1):9650 - PubMed
  34. Mol Oncol. 2016 Oct;10(8):1221-31 - PubMed
  35. Thyroid. 2016 Jan;26(1):1-133 - PubMed
  36. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3591-3599 - PubMed
  37. J Clin Oncol. 2018 Feb 10;36(5):438-445 - PubMed
  38. Int J Surg. 2017 May;41 Suppl 1:S13-S20 - PubMed
  39. Methods Mol Biol. 2014;1102:623-39 - PubMed

Publication Types

Grant support